the present invention is directed to proteins in which a heparin binding peptide is fused to a growth factor that promotes cell growth and survival . the compound thus formed is bound to the surface of cells which are then administered to damaged tissue . the growth factor is thereby maintained at the site of administration where it promotes repair .